Active substanceDextroseDextrose
Similar drugsTo uncover
  • Glucose
    solution d / infusion 
  • Glucose
    solution in / in 
    GROTEKS, LLC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution in / in 
  • Glucose
    solution d / infusion 
    GROTEKS, LLC     Russia
  • Glucose
    solution d / infusion 
    PIELDZHI, LLC     Russia
  • Glucose
    solution d / infusion 
    ATOLL, LLC     Russia
  • Glucose
    solution in / in 
  • Glucose
    solution in / in 
    ALVILS, LTD.     Russia
  • Glucose
    solution d / infusion 
    ATOLL, LLC     Russia
  • Glucose
    solution in / in 
    ATOLL, LLC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
    POLISAN NTPF, LLC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
  • Glucose
    solution in / in 
  • Glucose
    solution d / infusion 
    Baxter S.L.     Spain
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
    SAMSON-MED, LLC     Russia
  • Glucose
    solution in / in 
  • Glucose
    pills inwards 
  • Glucose
    solution d / infusion 
    ALIUM PFK, LLC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
    GEMATEK, LLC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
  • Glucose
    solution in / in 
    BINNOFARM, CJSC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution in / in 
  • Glucose
    solution d / infusion 
    BIOSINTEZ, PAO     Russia
  • Glucose
    solution in / in 
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
    DALHIMFARM, OJSC     Russia
  • Glucose
    solution in / in 
  • Glucose
    solution in / in 
    BIOSINTEZ, PAO     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution in / in 
    DALHIMFARM, OJSC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
    SAKHAMEDPROM, SUE     Russia
  • Glucose
    solution d / infusion 
    RESTER, CJSC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
    KRASFARMA, JSC     Russia
  • Glucose
    solution d / infusion 
    Kelun-Kazfarm, TOO     The Republic of Kazakhstan
  • Glucose Brown
    solution d / infusion 
  • Glucose bufus
    solution in / in 
    UPDATE OF PFC, CJSC     Russia
  • Glucose-Vial
    solution d / infusion 
    VIAL, LLC     Russia
  • Glucose-E
    solution d / infusion 
    ESKOM NPK, OAO     Russia
  • Glucose-Eskom
    solution in / in 
    ESKOM NPK, OAO     Russia
  • Glucose solution for infusions
    solution d / infusion 
    ALTAYVITAMINS, CJSC     Russia
  • Glucosterol
    solution d / infusion 
  • Dosage form: & nbspsolution for infusions
    Composition:

    5% solution

    1 liter of solution contains:

    active substance: dextrose monohydrate (in terms of anhydrous) 50.0 g;

    Excipients: sodium chloride 0.26 g; water for injection up to 1 liter.

    Theoretical osmolarity: 286 mOsm / l.

    10% solution

    1 liter of solution contains:

    active substance: dextrose monohydrate (in terms of anhydrous) 100.0 g;

    Excipients: sodium chloride 0.26 g; water for injection up to 1 liter.

    Theoretical osmolarity: 564 mOsm / l.

    20% solution

    1 liter of solution contains:

    active substance: dextrose monohydrate (in terms of anhydrous) 200.0 g;

    Excipients: sodium chloride 0.26 g; water for injection up to 1 liter.

    Theoretical osmolarity: 1120 mOsm / l.

    Description:

    Transparent, colorless (5% and 10% solutions) or slightly yellowish (20% solution) liquid.

    Pharmacotherapeutic group:Nutrition carbohydrate remedy
    ATX: & nbsp

    B.05.C   Irrigation solutions

    V.06.D   Other medications for nutrition

    V.04.C   Other diagnostic preparations

    Pharmacodynamics:

    Participates in various metabolic processes in the body. The infusion of dextrose solutions partially replenishes the water deficiency. Dextrose, entering the tissue, phosphorylated, turning into glucose-6-phosphate, which is actively included in many parts of the body's metabolism.

    5% dextrose solution is isotonic with blood plasma. Hypertensive (10% and 20%) solutions increase osmotic blood pressure, increase diuresis.

    Pharmacokinetics:

    It is absorbed completely by the body, the kidneys are not excreted (the appearance in the urine is a pathological sign).

    Indications:

    5%, 10%, 20% glucose solutions are used to fill the volume of fluid with isotonic extracellular dehydration and as a source of carbohydrates.

    5% glucose solution can be used both independently and for the dilution and transport of various drugs that are administered parenterally.

    Contraindications:

    Hypersensitivity, hyperglycemia, hyperlactacidemia, hyperhydration, postoperative disorders of dextrose utilization; circulatory disorders threatening cerebral edema, pulmonary edema, acute left ventricular failure, hyperosmolar coma, decompensated diabetes mellitus, intolerance to dextrose, incl. metabolic stress.

    Carefully:

    Decompensated chronic heart failure, chronic renal failure (oligo, anuria), hyponatremia, diabetes mellitus.

    Pregnancy and lactation:

    Glucose solutions during pregnancy and lactation can be used only under the condition of monitoring by the doctor.

    5% glucose solution can be used for indications during pregnancy and during lactation.

    Currently, sufficient clinical data on the use of 10% and 20% glucose solutions during pregnancy and during lactation are not available, so it is possible to use the drug in pregnant women and during lactation only when the expected benefit of the drug exceeds the possible risk of developing complications.

    When using the solution as a transport of other medicines, the effect of these additional drugs in pregnancy and lactation should be evaluated.

    Dosing and Administration:

    Intravenously drip.

    The concentration and dose of the dextrose solution is determined by several factors, including age, body weight and general condition of the patients.

    5% solution injected at a maximum rate of up to 7 ml (150 cap / min) (400 ml / h); the maximum daily intake for adults is 2 liters;

    10% glucose solution - up to 60 cap / min (3 ml / min); the maximum daily intake for adults is 1 liter;

    20% glucose solution - up to 30-40 cap / min (1.5-2 ml / min); the maximum daily intake for adults is 500 ml.

    In adults with a normal metabolism, the daily dose of dextrose administered should not exceed 4-6 g / kg, i.e. about 250 - 450 g (with a decrease in the intensity of metabolism - 30-40 ml / kg).

    Children for parenteral nutrition, along with fats and amino acids, 6 g of dextrose / kg / day are administered on the first day, followed by up to 15 g / kg / day. When calculating the dose of dextrose with the administration of 5% and 10% solutions, it is necessary to take into account the permissible volume of the injected fluid: for children with a weight of 2-10 kg - 100-165 ml / kg / day, children with a weight of 10-40 kg - 45-100 ml / kg / day.

    The rate of administration: at the normal state of metabolism, the maximum rate of dextrose administration to adults is 0.25-0.5 g / kg / h (with a decrease in the intensity of the metabolism, the rate of administration is reduced to 0.125-0.25 g / kg / h). In children, the rate of administration should not exceed 0.5 g / kg / h; which is 5 ml of solution - about 10 ml / min or 200 cap / min (20 cap = 1 ml).

    When using a solution of glucose as a solvent, the recommended dose is 50-250 ml per dose of the drug to be dissolved, the characteristics of which are determined and the rate of administration.

    For more complete assimilation of dextrose, administered in large doses, simultaneously with her, short-acting insulin is administered at the rate of 1 unit of insulin per 4-5 g of dextrose. The blood glucose content should be carefully monitored. To avoid hyperglycemia, the level of possible glucose oxidation should not be exceeded.

    Patients with diabetes mellitus are administered dextrose under the control of its content in blood and urine.

    Side effects:

    Immune system disorders: hypersensitivity, anaphylactic reactions (possible manifestations in patients with allergies to maize).

    Disorders from the metabolism and nutrition: hypokalemia, hypomagnesemia, hypophosphatemia, dehydration, hypervolemia, hyperglycemia.

    Heart Disease: acute ventricular failure.

    Vascular disorders: thrombosis of veins, phlebitis.

    Disorders from the kidneys and urinary tract: polyuria.

    General disorders and disorders at the site of administration: chills, fever, development of infection at the injection site, mild tenderness and thrombophlebitis at the site of intravenous administration.

    Overdose:

    Symptoms:

    Hyperglycemia, glucosuria, hyperglycemic hyperosmolar coma; hyperhydration, violation of water-electrolyte balance.

    Treatment:

    Stop the introduction of dextrose, introduce insulin, symptomatic therapy.
    Interaction:

    When combined with other drugs, it is necessary to visually control the pharmaceutical compatibility.

    Special instructions:

    For more complete assimilation of dextrose at the same time it can be administered subcutaneously from 4 to 5 units of short-acting insulin at a rate of 1The short-acting insulin dose is 4-5 grams of dextrose.

    Freezing during transportation is allowed.

    Effect on the ability to drive transp. cf. and fur:

    Clinical studies to assess the effect of the drug on the ability to manage vehicles and mechanisms have not been conducted.

    Form release / dosage:

    Solution for infusions, 5%, 10% and 20%.

    Packaging:

    100, 200, 250, 400, 500 or 1000 ml in polypropylene bottles with a scale and holder loop, sealed with welded polypropylene caps.

    One bottle together with instructions for use in a pack of cardboard.

    For hospitals

    From 1 to 40 vials of 100, 200, 250, 400, 500 or 1000 ml together with instructions for use in an amount equal to the number of vials in a corrugated box of cardboard.

    Storage conditions:

    Store at a temperature not exceeding 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2.5 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:On prescription
    Registration number:LP-002516
    Date of registration:01.07.2014 / 24.02.2015
    Expiration Date:01.07.2019
    Date of cancellation:2019-07-01
    The owner of the registration certificate:GROTEKS, LLC GROTEKS, LLC Russia
    Manufacturer: & nbsp
    Representation: & nbspGROTEKS, LLCGROTEKS, LLC
    Information update date: & nbsp02.05.2017
    Illustrated instructions
      Instructions
      Up